KRON
Companies
NASDAQ
Kronos Bio Inc.
Health Care
$0.87
-$0.08 (-8.42%)
Price Chart
Overview
About KRON
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.
Market Cap
$44.6M
Volume
699.0K
Avg. Volume
687.2K
P/E Ratio
-0.48920292
Dividend Yield
0.00%
Employees
80.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.87
Moderate Correlation
Volatility
High (0.67)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, KRON shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$44.6M
Volume699.0K
P/E Ratio-0.49
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
August 7, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025